| Literature DB >> 33898617 |
Annelies van der Kolk1, Natasja Lammers2, Marjolein Brusse-Keizer3, Job van der Palen3,4, Joyce Faber1, Reina Spenkelink-Visser5, Bernard J Thio2,3.
Abstract
OBJECTIVE: Asthma is the most common chronic disease in childhood and anti-inflammatory medication is the cornerstone of treatment. Inhalers are frequently used incorrectly when demonstrated in the hospital, suggesting poor technique at home. We aimed to 1) compare daily inhalation technique with the Diskus and Autohaler in asthmatic children by filming inhalations at home and 2) compare daily inhalation technique with technique demonstrated in the hospital.Entities:
Year: 2021 PMID: 33898617 PMCID: PMC8053909 DOI: 10.1183/23120541.00215-2019
Source DB: PubMed Journal: ERJ Open Res ISSN: 2312-0541
List of critical errors used for the scoring of inhalation technique#
| 1 | Device is not opened correctly until a “click” is heard | Inhaler cap is not removed before use |
| 2 | Device is not held horizontally with counter facing up while preparing (45° tolerance) | Inhaler is not held upright with lever on top (45° tolerance) |
| 3 | Lever is not pushed back until another “click” is heard | Lever is not pushed up before inhalation |
| 4 | Exhales into the device | After fully exhaling, teeth and lips are not sealed around mouthpiece |
| 5 | Mouthpiece is not correctly sealed between teeth and lips | Inhalation stops directly after firing the inhaler |
| 6 | Insufficiently deep inhalation | Insufficiently deep inhalation |
| 7 | No breath-hold for ≥10 s | No breath-hold for ≥10 s |
#: partly adopted from the standardised inhalation protocols distributed by the Lung Alliance Netherlands [9].
Characteristics of the study sample at baseline
| 16 | 16 | 32 | ||
| 0.144 | ||||
| Female | 8 (50) | 4 (25) | 12 (37.5) | |
| Male | 8 (50) | 12 (75) | 20 (62.5) | |
| 8.0±1.6 | 7.8±1.8 | 7.9±1.7 | 0.977 | |
| 14 (87.5) | 13 (81.3) | 27 (84.4) | 1.000 | |
| SABA | 14 (87.5) | 15 (93.8) | 29 (90.6) | 1.000 |
| LABA | 2 (12.5) | 2 (12.5) | 4 (12.5) | 1.000 |
| ICS | 11 (68.8) | 15 (93.8) | 26 (81.3) | 0.172 |
| NCS | 9 (56.3) | 5 (31.3) | 14 (43.8) | 0.143 |
| LTRA | 2 (12.5) | 2 (12.5) | 4 (12.5) | 1.000 |
Data are presented as n, n (%) or mean±sd, unless otherwise stated. SABA: short-acting β2-agonist; LABA: long-acting β2-agonist; ICS: inhaled corticosteroid; NCS: nasal corticosteroid; LTRA: leukotriene receptor antagonist. #: Diskus use in the morning and Autohaler in the evening; ¶: Autohaler use in the morning and Diskus in the evening.
Prevalence of different critical errors with the Diskus and Autohaler at home (n=27)#
| 1 | 0 (0) | 0 (0) |
| 2 | 271 (60.1) | 4 (6.3) |
| 3 | 3 (0.7) | 0 (0) |
| 4 | 66 (14.6) | 1 (1.6) |
| 5 | 0 (0) | 1 (1.6) |
| 6 | 83 (18.4) | 39 (61.9) |
| 7 | 28 (6.2) | 18 (28.6) |
| 451 (100) | 63 (100) |
Data are presented as n (%). #: analyses are based on 636 video clips with the Diskus and 663 with the Autohaler, made by 27 patients; ¶: critical error types are described in table 1.
FIGURE 1Survival function of percentage of patients without a critical error during the study period of 28 days, using the Diskus and Autohaler.
Inhalation technique at home and during demonstration in the hospital with the Diskus and Autohaler (n=27)#
| 44.0 (20.8–57.1) | 95.8 (87.5–100) | <0.001 | |
| 14 (10–22) | 1 (0–3) | <0.001 | |
| 19 (70.4) | 23 (85.2) | <0.001 |
Data are presented as median (interquartile range) or n (%), unless otherwise stated. #: analyses are based on 636 video clips with the Diskus and 663 with the Autohaler made by 27 patients; ¶: percentage of inhalations without a critical error; +: patients who showed a correct inhalation technique during demonstration in the hospital at the end of the study period of 28 days.
FIGURE 2Prevalence of the two most common critical errors at home using the Diskus and Autohaler, compared to the prevalence at demonstration in the hospital, expressed as percentage of total observations (n=636 for Diskus at home; n=663 for Autohaler at home; n=27 for both devices in the hospital).